Literature DB >> 22367831

Combined antithrombotic treatment with aspirin and clopidogrel for patients with capsular warning syndrome: a case report.

Talip Asil1, Nasf Ir, Fatih Karaduman, Bekir Cagli, Sedat Tuncel.   

Abstract

Capsular warning syndrome is characterized by recurrent transient ischemic attacks and is caused by microthrombosis or hypoperfusion of small-sized vessels. The pathophysiological basis of this syndrome is not well understood and currently a consensus has not been reached on its optimal treatment. In this study, we present 2 cases with favorable clinical outcomes after combined antithrombotic treatment with loading doses of clopidogrel and aspirin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367831     DOI: 10.1097/NRL.0b013e318247b9a5

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  4 in total

1.  Capsular warning syndrome.

Authors:  Vivek Nadarajan; Tolu Adesina
Journal:  BMJ Case Rep       Date:  2013-07-12

2.  rt-PA with Antithrombotic Therapies in a Case with Capsular Warning Syndrome.

Authors:  Yasuhiro Fuseya; Miyuki Kawamura; Eri Matsuda; Kozue Takada; Kiwamu Watanabe; Junko Fujitake; Yoshifumi Nakaya
Journal:  Intern Med       Date:  2017-02-15       Impact factor: 1.271

3.  Capsular warning syndrome: clinical analysis and treatment.

Authors:  Lanying He; Ronghua Xu; Jian Wang; Lili Zhang; Lijuan Zhang; Fangfang Zhou; Weiwei Dong
Journal:  BMC Neurol       Date:  2019-11-13       Impact factor: 2.474

4.  r-tPA with loading dose of clopidogrel and aspirin therapies for capsular warning syndrome attributed to middle cerebral artery atherosclerotic stenosis: A CARE-compliant case report.

Authors:  Jinghan Xu; Meiting Zhuang; Guanshui Bao; Yu Zhai; Guo-Yuan Yang; Gang Xue; Qiang Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.